Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 5168-5175

  Juedes, A E ^a   Ruddle, N H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035871635     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.5168     Document Type: Article

References (52)

1. Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligoclendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis
2. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis
3. Microglia induce CD4 T lymphocyte final effector function and death
4. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice
5. Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes
6. An immunoelectron microscopical study of the expression of class II major compatibility complex during chronic relapsing experimental allergic encephahistolomyelitis in Biozzi AB/H mice
7. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology
8. Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat
9. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization
10. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis
11. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice
12. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent
13. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats
14. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis: Evidence suggesting that most infiltrating T cells do not proliferate in the target organ
15. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis: The role of astrocytes
16. Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis: Analysis of basic protein-reactive cells in lymphoid organs and nervous system of dono and recipient animals
17. Separation and properties of lymphocytes obtained from the central nervous system
18. Global inhibition of IL-2 and IFN-γ, secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis
19. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis
20. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis
21. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells
22. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene
23. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis
24. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
25. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
26. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
27. Reciprocal stimulation between TNF-α and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis
28. A critical role for lymphotoxin in experimental allergic encephalomyelitis
29. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR δ chain gene
30. Cloning and expression of murine lymphotoxin cDNA
31. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing, and chronic experimental autoimmune encephalomyelitis
32. Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus
33. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system
34. + T cells compared
35. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: Regulation by Th1 cytokines
36. Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: Decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice
37. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process
38. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
39. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
40. Interferon-γ confers resistance to experimental allergic encephalomyelitis
41. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
42. T-cell co-stimulation through B7RP-1 and ICOS
43. ICOS co-stimulatory receptor is essential for T-cell activation and function
44. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats
45. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function
46. Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
47. Inhibition of macrophage Ia expression by nitric oxide
48. Class II transactivator and class II MHC gene expression in microglia: Modulation by the cytokines TGF-β, IL-4, IL-13 and IL-10
49. 2 and cyclic AMP-elevating agents
50. Antigen presentation in the central nervous system: The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed
51. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery
52. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice